AJP - GI AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (November 18, 2004). doi:10.1152/ajpgi.00300.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/G763    most recent
00300.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graupera, M.
Right arrow Articles by Garcia-Pagan, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graupera, M.
Right arrow Articles by Garcia-Pagan, J.-C.
Submitted on July 8, 2004
Accepted on November 13, 2004

SINUSOIDAL ENDOTHELIAL COX-1 DERIVED PROSTANOIDS MODULATE THE HEPATIC VASCULAR TONE OF CIRRHOTIC RAT LIVERS

Mariona Graupera1, Sandra March2, Pablo Engel2, Juan Rodes1, Jaume Bosch1, and Joan-Carles Garcia-Pagan1*

1 Hepatic Hemodynamic Laboratory, Liver Unit. Institut Malalties Digestives, University of Barcelona, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2 Immunology Unit, Department of Cellular Biology and Pathology, University of Barcelona, IDIBAPS, Medical School, Barcelona, Spain

* To whom correspondence should be addressed. E-mail: jcgarcia{at}clinic.ub.es.

Background/: CCl4 cirrhotic rat liver exhibits a hyperesponse to the {alpha}1- adrenergic agonist, methoxamine (Mtx) that is associated with enhanced thromboxane A2 (TXA2) production and is abrogated by Indomethacin. Aim/Methods: To further elucidate the molecular mechanisms involved in the hyperresponse to vasoconstrictors, portal perfusion pressure (PP) dose-response curves to Mtx were performed in CCl4 cirrhotic rats livers after preincubation with vehicle, the cyclooxygenase-1 (COX-1) selective inhibitor SC-560 and the cyclooxygenase-2 (COX-2) selective inhibitor SC-236. TXA2 production was determined in samples of the perfusate. COX-1 expression was analyzed and quantified in hepatocytes, Kupffer cells, sinusoidal endothelial cells (SEC) and hepatic stellate cells (HSC) isolated from control and cirrhotic rat livers by double immunofluorescence staining with specific markers for each population using flow cytometry or Western blot. Results: COX-1 protein levels were not significantly increased in cirrhotic livers, but COX-2 protein expression was increased. COX-1 inhibition, but not COX-2, significantly attenuated the response to Mtx, and prevented the increased production of TXA2. Cirrhotic livers showed an increased expression of COX-1 in SEC and reduced expression in HSC in comparison to control livers, while COX-1 was similarly distributed in Kupffer cells. Conclusion: Despite abundant hepatic COX-2 expression, the increased response to Mtx of cirrhotic livers is mainly dependent of COX-1. Up-regulation of COX-1 in cirrhotic SEC may be responsible for the hyperesponse to Mtx.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.